Palantir Technologies (NASDAQ:PLTR) remains a highly divisive stock for certain investors. On the one hand, this is a top-tier growth stock that’s certainly provided plenty in the way of gains for ...

A pair of veterans from the quantitative trading world have launched a blockchain startup that wants to help other crypto ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Despite a still tight venture capital market, new unicorns are still being created every month. Using data from Crunchbase and PitchBook, TechCrunch ...

Street Talk can reveal Syfe, advised by Sydney’s LoftusLane Capital, was granted due diligence overnight by SelfWealth’s board to firm up its 28¢ a share bid, which topped Bells’ 25¢ offer from late ...

The global AI market in aerospace and defense is projected to surge from approximately $28 billion today to a staggering $65 ...

State regulators with the California Department of Insurance have given Mercury General and Liberty Mutual subsidy Safeco the ...

It’s certainly true that Trump’s reentry into the White House has been defined in part by the very public role assumed by ...

While Musk functions as the head of the operation – proceeding in a manner that echoes early days of the tech billionaire’s ...

The Dallas bankruptcy trustee for GloriFi filed a lawsuit against Toby Neugebauer, the company CEO, alleging Neugebauer ...

We take a look at 3 binge-worthy new medical dramas from Max, Netflix, and AppleTV+ that take you inside the pulse-pounding chaos of the emergency ward.

In an interview with the Russian News Agency TASS last week, Vitaly Smirnov, an honorary member of the International Olympic ...